I have been running semaglutide for five years and the honest summary is that the effect is smaller than the internet suggests and real.
Baseline first. Without a baseline the after picture is decoration.
What the GLP-1 class does pharmacologically does not require the subjective effect to be large to be real.
The comparison group matters more than the compound when the outcome is something as fuzzy as focus.
Titration is slow by design and rushing it is how people end up miserable.
Happy to be corrected on any of the above.
Loose evidence is not nothing, but a washout either side is the only reason to trust your own take.
Underdosing and tolerance are indistinguishable from the inside, and everyone picks the flattering explanation.
Test one thing at a time. It feels slower and it is the only way to learn anything.
Read the methods section. It is the only part that says whether the conclusion is allowed to exist.
How long before you can reasonably say something is or is not doing anything?
Is a baseline blood test really necessary before starting something like this?
What is the first thing you would read if you were starting from zero? Same for me with semaglutide, unfortunately.
An inconclusive account is useful if it stops the next person mistaking a story for a controlled comparison.
Same here.